TY - JOUR
T1 - Evaluation of Local Rod and Cone Function in Stargardt Disease
AU - Stingl, Krunoslav
AU - Hoyng, Carel
AU - Kempf, Melanie
AU - Kohl, Susanne
AU - Jung, Ronja
AU - Righetti, Giulia
AU - Kühlewein, Laura
AU - Pohl, Lisa
AU - Kortüm, Friederike
AU - Kelbsch, Carina
AU - Wilhelm, Barbara
AU - the SORAPRAZAN consortium
AU - Peters, Tobias
AU - Stingl, Katarina
AU - Wheeler-Schilling, Thomas
AU - Diether, Sigrid
AU - Klein, Wolfgang
AU - Mirow, Roland
AU - Smerud, Knut
AU - Jungmann, Oliver
AU - Müller, Hans
AU - Fsadni, Mario
AU - Lotery, Andrew
AU - Dhooge, Patty
AU - Boon, Camiel
AU - Parodi, Maurizio Battaglia
AU - Herrmann, Philipp
AU - Möller, Philipp
N1 - Funding Information: The “Soraprazan” project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 779317. We thank support by Open Access Publishing Fund of University of Tübingen. Carina Kelb-sch was supported by Egon Schumacher-Stiftung, a private foundation without commercial interests. Katarina Stingl, Carel Hoyng, Susanne Kohl, and Melanie Kempf are members of the ERN-EYE (European Reference Network for Rare Eye Diseases). Funding Information: The ?Soraprazan? project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 779317. We thank support by Open Access Publishing Fund of University of T?bingen. Carina Kelbsch was supported by Egon Schumacher-Stiftung, a private foundation without commercial interests. Katarina Stingl, Carel Hoyng, Susanne Kohl, and Melanie Kempf are members of the ERN-EYE (European Reference Network for Rare Eye Diseases). Publisher Copyright: © 2022 The Authors
PY - 2022/3/1
Y1 - 2022/3/1
N2 - PURPOSE. In this study, chromatic pupil campimetry (CPC) was used to map local functional degenerative changes of cones and rods in Stargardt disease (STGD1). METHODS. 19 patients (age 36 ± 8 years; 12 males) with genetically confirmed ABCA4 mutations and a clinical diagnosis of STGD1 and 12 age-matched controls (age 37 ± 11 years; 2 males) underwent scotopic (rod-favoring) and photopic (cone-favoring) CPC. CPC evaluates the local retinal function in the central 30° visual field via analysis of the pupil constriction to local stimuli in a gaze-corrected manner. RESULTS. Scotopic CPC revealed that the rod function of patients with STGD1 inside the 30° visual field was not impaired when compared with age-matched controls. However, a statistically significant faster pupil response onset time (∼ 40 ms) was observed in the measured area. Photopic CPC showed a significant reduction of the central cone function up to 6°, with a minor, non-significant reduction beyond this eccentricity. The time dynamic of the pupillary response in photopic CPC did not reveal differences between STGD1 and controls. CONCLUSIONS. The functional analysis of the macular region in STGD1 disease indicates reduced central cone function, corresponding to photoreceptor degeneration. In contrast, the rod function in the central area was not affected. Nevertheless, some alteration of the time dynamics in the rod system was observed indicating a complex effect of cone degeneration on the functional performance of the rod system. Our results should be considered when interpreting safety and efficacy in interventional trials of STGD1.
AB - PURPOSE. In this study, chromatic pupil campimetry (CPC) was used to map local functional degenerative changes of cones and rods in Stargardt disease (STGD1). METHODS. 19 patients (age 36 ± 8 years; 12 males) with genetically confirmed ABCA4 mutations and a clinical diagnosis of STGD1 and 12 age-matched controls (age 37 ± 11 years; 2 males) underwent scotopic (rod-favoring) and photopic (cone-favoring) CPC. CPC evaluates the local retinal function in the central 30° visual field via analysis of the pupil constriction to local stimuli in a gaze-corrected manner. RESULTS. Scotopic CPC revealed that the rod function of patients with STGD1 inside the 30° visual field was not impaired when compared with age-matched controls. However, a statistically significant faster pupil response onset time (∼ 40 ms) was observed in the measured area. Photopic CPC showed a significant reduction of the central cone function up to 6°, with a minor, non-significant reduction beyond this eccentricity. The time dynamic of the pupillary response in photopic CPC did not reveal differences between STGD1 and controls. CONCLUSIONS. The functional analysis of the macular region in STGD1 disease indicates reduced central cone function, corresponding to photoreceptor degeneration. In contrast, the rod function in the central area was not affected. Nevertheless, some alteration of the time dynamics in the rod system was observed indicating a complex effect of cone degeneration on the functional performance of the rod system. Our results should be considered when interpreting safety and efficacy in interventional trials of STGD1.
KW - Stargardt disease
KW - chromatic pupil campimetry
KW - cone function
KW - rod function
UR - http://www.scopus.com/inward/record.url?scp=85126076207&partnerID=8YFLogxK
U2 - https://doi.org/10.1167/iovs.63.3.6
DO - https://doi.org/10.1167/iovs.63.3.6
M3 - Article
C2 - 35262734
SN - 0146-0404
VL - 63
JO - Investigative Ophthalmology and Visual Science
JF - Investigative Ophthalmology and Visual Science
IS - 3
M1 - 6
ER -